Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T20:41:20.142Z.
Calculation as of: 2026-10-06T20:41:20.142Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c1a6838803f42d6ea125a2cca62df7e150df7eb7d5f2d1fff74d5c1a91b3d340
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$483.54M
EV/FCF Ratio
11.00x
TTM Avg
7.76x
3Y Avg
12.39x
5Y Avg
16.55x
Market Cap
$475.91M
EV/FCF Ratio
N/A
TTM Avg
36.88x
3Y Avg
36.88x
5Y Avg
36.88x
Market Cap
$472.23M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$471.57M
EV/FCF Ratio
N/A
TTM Avg
997.52x
3Y Avg
857.93x
5Y Avg
857.93x
Market Cap
$500.52M
EV/FCF Ratio
16.66x
TTM Avg
14.11x
3Y Avg
11.22x
5Y Avg
269.81x
Market Cap
$502.81M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evolus, Inc. (EOLS) | $486.01M | N/A | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 11.00x | 7.76x | 12.39x | 16.55x |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | N/A | 36.88x | 36.88x | 36.88x |
| Oculis Holding AG (OCS)vs › | $498.52M | N/A | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $471.65M | N/A | 5.27x | 5.30x | 11.22x |
| Cerus Corporation (CERS)vs › | $471.57M | N/A | 997.52x | 857.93x | 857.93x |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.52M | 16.66x | 14.11x | 11.22x | 269.81x |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $502.81M | N/A | N/A | N/A | N/A |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
